Specialty Area
Spotlight
Topics
Institute for Value-Based Medicine
About AJMC
Podcasts
CE
Subscribe
- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Advancing IgA Nephropathy Care: Emerging Therapies, Unmet Needs, and Economic Considerations : Episode 23
Closing Thoughts About IgA Nephropathy Treatment
Panelists discuss how the management of immunoglobulin A (IgA) nephropathy is undergoing a transformative shift from symptom control to targeted disease modification, with emerging therapies offering new hope for patients while requiring thoughtful integration into clinical practice and health care systems.
EP: 1.Advancing IgA Nephropathy Care: Emerging Therapies, Unmet Needs, and Economic Considerations
EP: 2.Introduction to IgA Nephropathy
EP: 3.Pathogenesis of IgA Nephropathy: The 4-Hit Cascade, A Proliferation-Inducing Ligand (APRIL), and cytokines
EP: 4.Diagnosing IgA Nephropathy
EP: 5.Signs and Symptoms of IgA Nephropathy
EP: 6.Challenges in Timely Identification of IgA Nephropathy
EP: 7.Clinical Impact of IgA Nephropathy and Quality of Life
EP: 8.Overview of Treatment Landscape for IgA Nephropathy: Standard of Care and KDIGO Guidelines
EP: 9.Current Treatments for IgA Nephropathy and the 4-Hit Cascade
EP: 10.Gaps in Patient Care for IgA Nephropathy
EP: 11.Emerging Anti-BAFF and Anti-APRIL Therapies
EP: 12.Emerging Therapies: Other Strategies and Important Considerations
EP: 13.The Promise of Emerging Therapies for IgA Nephropathy and Future KDIGO Guidelines
EP: 14.Sequencing and Individualizing Treatments for IgA Nephropathy
EP: 15.Measuring Success in IgA Nephropathy in Clinical Practice
EP: 16.Economic Impact of IgA Nephropathy for Patients
EP: 17.Early Diagnosis and Cost Mitigation in IgA Nephropathy
EP: 18.Cost Implications of Modulating IgA Nephropathy Disease Course
EP: 19.Patient-Reported Outcomes in the Treatment of IgA Nephropathy
EP: 20.Future Possibilities for Step Therapy in IgA Nephropathy Treatment
EP: 21.Key Managed Care Considerations for IgA Nephropathy Treatment
EP: 22.Key Economic Considerations in IgA Nephropathy: Progression to Chronic Kidney Disease
Now Viewing
EP: 23.Closing Thoughts About IgA Nephropathy Treatment
Related Videos
Related Content
